VAERS reports by lot

Merck HPV lot M044717: VAERS reports

45 VAERS reports list lot M044717 as a Merck HPV vaccine, received between 2017-04-21 and 2020-08-11. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
45
Reports
7%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological1924%
Injection-site / Local reaction1519%
Dermatological (non-injection-site)1114%
General / Systemic (non-local)1114%
Cardiac / Cardiovascular911%
Gastrointestinal79%
Respiratory45%
Allergic / Anaphylactic22%
Musculoskeletal11%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Virginia14
Texas5
Washington3
California3
Illinois2
Connecticut2
Oregon2
Michigan2
New Mexico1
Utah1
Nevada1
Maryland1

Reports by month received

2017-041
2017-051
2017-067
2017-074
2017-087
2017-0917
2017-102
2017-121
2018-021
2018-061
2018-101
2020-071
2020-081

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.